首页 | 本学科首页   官方微博 | 高级检索  
检索        

针刺联合温胆汤治疗痰瘀互结型稳定型心绞痛的疗效观察
引用本文:刘莉,张丹丹,邹国良,隋艳波,韩宇博,孙碧鸿.针刺联合温胆汤治疗痰瘀互结型稳定型心绞痛的疗效观察[J].上海针灸杂志,2021(4):379-384.
作者姓名:刘莉  张丹丹  邹国良  隋艳波  韩宇博  孙碧鸿
作者单位:黑龙江中医药大学附属第一医院;黑龙江中医药大学
基金项目:国家自然科学基金面上项目(82074346,81873284,81573935);春晖计划项目(HLJ2019033);黑龙江中医药大学校科研基金资助项目(2019TD01,2019BS02);黑龙江中医药大学“双一流”中西医结合学科发展助力基金(HLJSYL1001)。
摘    要:目的观察针刺联合温胆汤加减治疗痰瘀互结型稳定型心绞痛的临床疗效。方法将符合纳入标准的60例痰瘀互结型稳定型心绞痛患者按照随机数字表法分为对照组和治疗组,每组30例。对照组给予西医常规治疗,治疗组在对照组治疗基础上加以针刺和温胆汤加减治疗。治疗4周后,比较两组安全性指标(血肝/肾功能指标)、中医证候评分、中医证候疗效、血脂指标和相关临床指标(心绞痛发作频次、发作持续时间和硝酸甘油用量)。结果两组治疗后安全性指标(血肝/肾功能指标)与治疗前比较差异无统计学意义(P>0.05),治疗后组间比较差异无统计学意义(P>0.05)。两组治疗后中医证候评分均较治疗前显著降低(P<0.05),治疗组治疗后中医证候评分明显低于对照组(P<0.05)。治疗后,治疗组和对照组中医证候疗效总有效率分别为90.0%和70.0%,两组比较差异有统计学意义(P<0.05)。治疗组治疗后的血脂指标均优于对照组,差异均有统计学意义(P<0.05)。治疗后,治疗组心绞痛发作频次、发作持续时间及硝酸甘油用量均优于对照组,组间差异均具有统计学意义(P<0.05)。结论在西药治疗基础上予针刺联合温胆汤加减治疗可改善痰瘀互结型稳定型心绞痛的中医证候,提高中医证候疗效,改善血脂,减少心绞痛发作频次、发作持续时间和硝酸甘油用量,且无肝肾损伤,安全性高。

关 键 词:针刺疗法  针药并用  痰瘀互结  冠状动脉疾病  心绞痛  稳定型  温胆汤

Observations on the Efficacy of Acupuncture plus Wen Dan Decoction for Stable Angina Pectoris of Phlegm and Blood Stasis Type
LIU Li,ZHANG Dan-dan,ZOU Guo-liang,SUI Yan-bo,HAN Yu-bo,SUN Bi-hong.Observations on the Efficacy of Acupuncture plus Wen Dan Decoction for Stable Angina Pectoris of Phlegm and Blood Stasis Type[J].Shanghai Journal of Acupuncture and Moxibustion,2021(4):379-384.
Authors:LIU Li  ZHANG Dan-dan  ZOU Guo-liang  SUI Yan-bo  HAN Yu-bo  SUN Bi-hong
Institution:(First Affiliated Hospital,Heilongjiang University of Chinese Medicine,Harbin 150040,China;Heilongjiang University of Chinese Medicine,Harbin 150040,China)
Abstract:Objective To observe the clinical efficacy of acupuncture plus modified Wen Dan decoction for stable angina pectoris of phlegm and blood stasis type.Method Sixty patients with stable angina pectoris of phlegm and blood stasis type meeting the diagnostic criteria were allocated,using a random number table,to control and treatment groups,with 30 cases in each group.The control group received conventional Western medical treatment and the treatment group,acupuncture plus modified Wen Dan decoction in addition.Safety indicators(blood liver/kidney function indicators),TCM syndrome scores,therapeutic effects on TCM syndrome,blood lipid indicators and related clinical indicators(angina attack frequency,attack duration and nitroglycerin dosage)were compared between the two groups after four weeks of treatment.Result There were no statistically significant pre-/post-treatment differences in safety indicators(blood liver/kidney function indicators)in the two groups(P>0.05)and no post-treatment differences between the two groups(P>0.05).After treatment,the TCM syndrome scores decreased significantly in the two groups compared with before(P<0.05)and was significantly lower in the treatment group than in the control group(P<0.05).After treatment,the total efficacy rate for TCM syndrome was 90.0%in the treatment group,versus 70.0%in the control group,with a statistically significant difference between the two groups(P<0.05).After treatment,blood lipid indicators were better in the treatment group than in the control group with statistically significant differences between the two groups(P<0.05).After treatment,angina attack frequency,attack duration and nitroglycerin dosage were better in the treatment group than in the control group,with statistically significant differences between the two groups(P<0.05).Conclusion Acupuncture plus modified Wen Dan decoction on the basis of Western medical treatment can improve the TCM syndromes,increase the total efficacy rate for TCM syndrome,improve blood lipids and reduce angina attack frequency,attack duration and nitroglycerin dosage without liver and kidney injuries and with safety in stable angina pectoris of phlegm and blood stasis type.
Keywords:Acupuncture therapy  Acupuncture medication combined  Phlegm and blood stasis  Coronary disease  Angina  stable  Wen Dan decoction
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号